And higher doses have also occasionally been linked to eye issues that do not occur at lower levels
As GLP-1 agonists have garnered attention for management of obesity due to their effect on reducing insulin sensitivity, they are now being considered a therapeutic option for the treatment of PCOS (polycystic ovarian syndrome), one of the most common causes of subfertility, diagnosed via Rotterdams criteria: oligomenorrhea, hyperandrogenism and polycystic ovaries (97)
There is a high rate Trusted Source American Journal of Clinical Nutrition Go to source of metabolic disorders, including obesity and type 2 diabetes, in this population
If you were to inject doses too close together, the concentration of the medication could spike to a level your body isnt prepared for
Supports anti-aging and immunity
Human studies about this use are lacking [8]